Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 24, 2019

DrugPatentWatch Database Preview

NATPARA Drug Profile

« Back to Dashboard

Summary for Tradename: NATPARA

Patents:	963
Applicants:	1
BLAs:	1
Suppliers: see list	1
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for NATPARA

Pharmacology for NATPARA

Ingredient-type	Parathyroid Hormone

US Patents for NATPARA

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	➤ Sign Up	ASAHI KASEI PHARMA CORPORATION (Tokyo, JP)	➤ Sign Up	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	➤ Sign Up	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	➤ Sign Up	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	➤ Sign Up	Novartis AG (Basel, CH)	➤ Sign Up	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	➤ Sign Up	ASCENDIS PHARMA A/S (Hellrup, DK)	➤ Sign Up	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	➤ Sign Up	Immunomedics, Inc. (Morris Plains, NJ)	➤ Sign Up	RX	Orphan	search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for NATPARA

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
Australia	2622301	➤ Sign Up
European Patent Office	2007416	➤ Sign Up
Brazil	9711002	➤ Sign Up
European Patent Office	0911342	➤ Sign Up
Japan	2005021157	➤ Sign Up
Country	Patent Number	Estimated Expiration

Supplementary Protection Certificates for NATPARA

Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
CA 2010 00032	Denmark	➤ Sign Up	PRODUCT NAME: DENOSUMAB
PA2010013	Lithuania	➤ Sign Up	PRODUCT NAME: DENOSUMABUM; REGISTRATION NO/DATE: EU/1/10/618/001, 2010 05 26, EU/1/10/618/002, 2010 05 26, EU/1/10/618/003, 2010 05 26, EU/1/10/618/004 20100526
300741	Netherlands	➤ Sign Up	PRODUCT NAME: CICLOSPORINE (EYE DROP EMULSION); REGISTRATION NO/DATE: EU/1/15/990 20150323
30/2001	Austria	➤ Sign Up	PRODUCT NAME: RECOMBINANTES HUMANES OSTEOGENES PROTEIN-1 (OP 1); REGISTRATION NO/DATE: EU/1/01/179/001 20010517
300864	Netherlands	➤ Sign Up	PRODUCT NAME: ETELCALCETIDE OF EEN ZOUT DAARVAN, MET INBEGRIP VAN ETELCALCETIDEHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/16/1142/001-012 20161115
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.